Indo Borax and earnings calls.

Indo Borax delivered an exceptional Q1 FY27 with 31% revenue growth to ₹70.36Current reported value: 70.36. No comparable prior figure is available in the source record. crore and 59% PAT growth to ₹16.25Current reported value: 16.25. No comparable prior figure is available in the source record. crore, driven by new leadership, capacity optimization, and improved realizations. EBITDA margin expanded to 28.1%Current reported value: 28.1%. No comparable prior figure is available in the source record. (up 530bps YoY) as raw material costs were largely passed through. The company reiterated FY27 guidance of ₹250-260 crore revenue with 20% EBITDA margins, noting Q2 will be seasonally weaker. The ₹250 crore Kronox acquisition (64.26% stake) provides cross-selling synergies through combined customer base and geographic reach, with Kronox's ₹110 croreCurrent ₹110 crore. Reported change: Phase 1: ₹55-60 crore. capex to be funded by its existing ₹80 crore cash and internal accruals. Management targets ₹50 crore capexCurrent reported value: ₹50 crore capex. No comparable prior figure is available in the source record. over 2-3 years for boron oxide and boric acid capacity expansion. DOT production guidance of 1,500 tonnesCurrent 1,500 tonnes. Reported change: +67% vs FY26. (from 900 last year) offers forward integration benefits. Key risks include boric acid price volatility from geopolitical factors, integration execution challenges across two listed entities, and the substantial ₹390 crore debt load for the acquisition relative to current profitability.